Pricing Concerns Delaying Sanofi’s Turkey Insulin Investment?
Executive Summary
Despite the political turmoil, Sanofi appears keen to invest in the local manufacturing of an insulin product in Turkey if the government “opens the way”, but is holding off over pricing worries.
You may also be interested in...
Turkey Jostles For Slice Of Biologics Manufacturing Pie
Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.
Turkey Company Roundup: Roche Case Reopens, Sanofi Starts Exports
The Supreme Court in Turkey has cancelled a statute of limitations decision in a Roche legal case, with some ex-managers and bureaucrats to be retried. Meanwhile, Sanofi Turkey has become the first pharmaceutical company to export antibiotics to Japan from a production site in Turkey, the AIFD has elected a chairman, and Lilly has made new appointments.
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.